Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Affiliations

• ¹ Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
• ² Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
• ³ Pasarow Mass Spectrometry Laboratory, University of California Los Angeles, Los Angeles, CA, 90095, USA.
• ⁴ Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, 90095, USA.
• ⁵ Office of Laboratory Animal Care, University of California Berkeley, Berkeley, CA, 94720, USA.
• ⁶ Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. [email protected].
• ⁷ UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, CA, 90095, USA. [email protected].
• ⁸ Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA. [email protected].
• ⁹ Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. [email protected].
• ¹⁰ The VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA. [email protected].